Clinical Trial: PCCT-Defined High-Risk Plaque and Future Coronary Events: The PREDICT Study

U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07822737) titled 'PCCT-Defined High-Risk Plaque and Future Coronary Events: The PREDICT Study' on July 12.

Brief Summary: This prospective cohort study aims to determine whether high-risk coronary plaques identified by novel Photon-Counting Detector CT (PCCT) independently predict future major adverse cardiovascular events (MACE). Participants will be followed for MACE and revascularization. The primary hypothesis is that the incidence of MACE is significantly higher in patients with PCCT-defined high-risk plaque than in those without. Additionally, patients will undergo Optical Coherence Tomography (OCT) and angiography within a month after PCCT; P...